VEGF-A - TOMIRLAR ENDOTELIYSI O'SISH FAKTORI SURUNKALI YO'LDOSH PATOLOGIYASI BO'LGAN BEMORLARDA COVID 19 YANGI KORONAVİRUS INFEKSIYASINING OG'IR KECHISHI BILAN BOG'LIQ ENDOTELIAL DISFUNKSIYANING MARKERI SIFATIDA.
##article.subject##:
Covid 19, comorbidity, vascular endothelial growth factor (VEGF A), endothelial dysfunction.##article.abstract##
Ushbu tadqiqotda qon tomir endotelial o‘sish omili A (VEGF-A)ning COVID-19 ning og‘ir namoyon bo‘lishi, xususan, diabet, gipertenziya, semizlik va yurak-qon tomir kasalliklari kabi surunkali kasalliklarga chalingan shaxslarda endotelial disfunktsiyaning potentsial biomarkeri sifatidagi ahamiyati ko‘rib chiqiladi. Endotelial disfunktsiya og'ir SARS-CoV-2 infektsiyasida asosiy patologik xususiyat sifatida paydo bo'lib, mikrotromboz, haddan tashqari oshirilgan tomir o'tkazuvchanligi va tizimli yallig'lanish reaktsiyalariga yordam beradi. tabaqalanish, prognoz va terapevtik qarorlar qabul qilish. Bundan tashqari, VEGF-A yuqori xavf ostida bo'lgan bemorlarda endotelial disfunktsiyani va uning klinik oqibatlarini yumshatishga qaratilgan qo'shimcha terapiya uchun maqsad sifatida o'rganilishi mumkin
Библиографические ссылки
Podzolkov, VI, Bragina, AE, Tarzimanova, AI, Vasilyeva, LV, Batrakova, EV, Lobova, NV, ... & Khachuroeva, MM (2021). Post-Covid syndrome and tachycardia: theoretical foundations and treatment experience. Rational pharmacotherapy in cardiology, 17(2), 256-262.(in Russian).
Svetozarsky, N. L., Artifexova, A. A., & Svetozarsky, S. N. (2015). Vascular endothelial growth factor: biological properties and practical significance (literature review). Journal of Siberian Medical Sciences, (5), 24.(in Russian).
Talotta, R. (2022). Impaired VEGF-A-mediated neurovascular crosstalk induced by SARS-CoV-2 spike protein: a potential hypothesis explaining long COVID-19 symptoms and COVID-19 vaccine side effects?. Microorganisms, 10(12), 2452.(in Russian).
Nekaeva, ES, Bolshakova, AE, Malysheva, ES, Galova, EA, Makarova, EV, Nekrasova, TA, ... & Fomin, IV (2021). Gender features of the course of the new coronavirus infection COVID-19 in mature individuals. Modern technologies in medicine, 13(4), 16-26. (in Russ).
Zaitsev, A. A., Savushkina, O. I., Chernyak, A. V., Kulagina, I. Ts., & Kryukov, E. V. (2020). Clinical and functional characteristics of patients who had the new coronavirus infection COVID-19. Practical Pulmonology, (1), 78-81. (in Russ).
Garg S. et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020 //Morbidity and mortality weekly report. – 2020. – T. 69. – No. 15. – P. 458. (in Russ).
Datta, S. D., Talwar, A., & Lee, J. T. (2020). A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. Jama, 324(22), 2251-2252. (in Russ).
Grigorenko, E., Ruzanov, D., & Statkevich, T. (2020). Coronavirus infection COVID-19 and comorbidity. Science and Innovation, (7 (209)), 50-60. (in Russ).
Kokaeva, IO, Zhernakova, Yu. V., & Blinova, N. B. (2022). Endothelial dysfunction in patients with COVID-19 is a key mechanism for the development of complications. Systemic hypertension, 19(4), 37-44. (in Russ).
Barbarash, O. L., Karetnikova, V. N., Kashtalap, V. V., Zvereva, T. N., & Kochergina, A. M. (2020). Novel coronavirus disease (COVID-19) and cardiovascular diseases. Complex Issues of Cardiovascular Diseases, 9(2), 17-28.(in Russian).
